投資評等
最後更新日期：2024/4/18
升級(Upgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2015/4/13 | UBS | Neutral >> Buy | $370 >> $565 |
| 2015/1/14 | Stifel | Hold >> Buy | |
| 2014/4/17 | Pacific Crest | Sector Perform >> Outperform | 500 |
| 2013/7/19 | Northland Capital | Under Perform >> Market Perform | $150 >> $225 |
| 2013/4/19 | National Alliance Capital Mkts | Market Perform >> Accumulate | $101.77 >> $186.64 |
| 2012/8/21 | Caris & Company | Below Average >> Average | |
| 2011/10/26 | Hudson Square Research | Hold >> Buy | 110 |
| 2011/10/11 | Hudson Square Research | Sell >> Hold | |
| 2011/9/22 | UBS | Sell >> Neutral | $185 >> $130 |
| 2011/4/26 | Maxim Group | Sell >> Hold | |
| 2011/1/27 | Caris & Company | Average >> Above Average | $186 >> $224 |
| 2011/1/27 | Morgan Keegan | Underperform >> Mkt Perform | |
| 2010/10/21 | Oppenheimer | Underperform >> Outperform | $110 >> $200 |
| 2010/4/22 | Citigroup | Hold >> Buy | |
| 2010/1/28 | Wedbush Morgan | Underperform >> Neutral | $50 >> $60 |
| 2010/1/28 | FBR Capital | Mkt Perform >> Outperform | $48 >> $71 |
| 2010/1/28 | Jefferies & Co | Hold >> Buy | $52 >> $65 |
| 2010/1/28 | Merriman | Neutral >> Buy | |
| 2009/8/19 | Kaufman Bros | Hold >> Buy | $48 >> $53 |
| 2009/6/17 | Wedbush Morgan | Hold >> Buy | 48 |
| 2009/6/15 | Caris & Company | Above Average >> Buy | 52 |
| 2009/5/19 | Lazard Capital Mkts | Sell Hold | |
| 2009/4/27 | Citigroup | Hold Buy | $37 $52 |
| 2007/4/20 | Banc of America Sec | Sell Neutral | 20 |
| 2006/9/6 | JP Morgan | Underweight Overweight | |
| 2006/6/22 | Lehman Brothers | Equal-weight Overweight | |
| 2005/9/27 | Bear Stearns | Peer Perform->Outperform | |
| 2005/8/4 | Jefferies Co | Hold->Buy | 25 |
| 2005/7/26 | CSFB | Neutral->Outperform | 26 |
| 2005/7/26 | Piper Jaffray | Market Perform->Outperform | |
| 2005/5/16 | Thomas Weisel | Peer Perform->Outperform | |
| 2005/2/25 | Marquis Investment Research | Sell->Hold | 13 |
| 2005/1/25 | Avondale Partners | Mkt Perform->Mkt Outperform | |
| 2004/12/8 | Roth Capital | Sell->Neutral | 11.6 |
| 2004/10/1 | Roth Capital | Neutral->Buy | 29.1 |
| 2004/3/29 | Roth Capital | Neutral->Buy | $36 |
降級(Downgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->降級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2014/10/16 | CRT Capital | Buy >> Fair Value | $510 >> $375 |
| 2013/9/11 | BTIG Research | Buy >> Neutral | |
| 2012/12/6 | Caris & Company | Average >> Below Average | |
| 2011/9/16 | Caris & Company | Above Average >> Average | |
| 2010/11/23 | Caris & Company | Above Average >> Average | |
| 2010/7/22 | Canaccord Genuity | Buy >> Hold | $95 >> $107 |
| 2010/6/30 | Hudson Square Research | Hold >> Sell | 78 |
| 2010/4/9 | Wedbush | Neutral >> Underperform | $60 >> $60 |
| 2010/4/7 | Barclays Capital | Overweight >> Equal Weight | $72 >> $88 |
| 2010/3/3 | Susquehanna Financial | Positive >> Neutral | |
| 2010/3/3 | Kaufman Bros | Buy >> Hold | 69 |
| 2009/12/4 | Citigroup | Buy >> Hold | 59 |
| 2009/12/1 | Merriman | Buy >> Neutral | |
| 2009/10/16 | Caris & Company | Buy >> Above Average | |
| 2009/7/24 | Wedbush Morgan | Outperform >> Neutral | 48 |
| 2009/7/24 | Oppenheimer | Perform >> Underperform | $35 >> $38 |
| 2009/4/14 | Wedbush Morgan | Buy Hold | |
| 2009/3/13 | Janney Mntgmy Scott | Neutral Sell | |
| 2007/1/12 | JP Morgan | Overweight Neutral | |
| 2006/1/20 | Bear Stearns | Outperform Peer Perform | |
| 2005/11/28 | Thomas Weisel | Outperform->Peer Perform | |
| 2005/10/5 | Avondale Partners | Mkt Outperform->Mkt Perform | |
| 2005/1/25 | Roth Capital | Neutral->Sell | 11.6 |
| 2004/10/15 | WR Hambrecht | Hold->Sell | |
| 2004/10/15 | Pacific Growth Equities | Over Weight->Equal Weight | |
| 2004/10/15 | Roth Capital | Buy->Sell | 29.1 |
| 2004/10/15 | Piper Jaffray | Outperform->Market Perform | 42 |
| 2004/10/15 | Jefferies Co | Buy->Hold | |
| 2004/10/15 | Marquis Investment Research | Buy->Sell | |
| 2004/10/15 | CSFB | Outperform->Neutral | |
| 2004/10/15 | Smith Barney Citigroup | Buy->Hold | |
| 2004/2/24 | First Albany | Buy->Neutral | |
| 2003/10/6 | Roth Capital | Buy -> Neutral | |
首次予以評等(Coverage Initiated)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 目標股價 |
| 2014/6/26 | Barclays | Underweight | 420 |
| 2013/8/8 | Robert W. Baird | Neutral | 263 |
| 2013/4/15 | BTIG Research | Buy | |
| 2013/1/22 | National Alliance Capital Mkts | Market Perform | 102 |
| 2010/10/14 | Dougherty & Company | Neutral | 140 |
| 2010/3/10 | Canaccord Adams | Buy | |
| 2009/11/17 | Collins Stewart | Buy | 73 |
| 2009/9/15 | JP Morgan | Overweight | 53 |
| 2009/6/5 | Credit Suisse | Underperform | 31 |
| 2009/5/20 | Wunderlich | Buy | 48 |
恢復投資評等(Coverage Resumed)
| 日期/Date | 券商/Brokerage Firm | 恢復評等後等級/Resumed Rating | 目標股價Target |
| 2014/11/25 | Stifel | Hold | 380 |
| 2011/11/22 | Canaccord Genuity | Sell | 60 |
| 2011/1/5 | Canaccord Genuity | Buy | 225 |
| 2009/7/2 | Stifel Nicolaus | Buy | 53 |
重申相同投資評等(Coverage Reiterated)
| 日期/Date | 券商
Brokerage Firm | 重申相同投資評等
Reiterated Rating | 新目標價
New Target |
| 2015/10/15 | MKM Partners | Buy | $130 >> $145 |
| 2015/4/16 | MKM Partners | Buy | $530 >> $690 |
| 2013/7/12 | Barclays | Equal Weight | $220 >> $250 |
| 2012/7/23 | Caris & Company | Below Average | $56 >> $59 |
| 2012/4/24 | Canaccord Genuity | Sell | $66 >> $68 |
| 2011/11/29 | Canaccord Genuity | Sell | $60 >> $57 |
| 2011/11/22 | Caris & Company | Below Average | $77 >> $59 |
| 2011/11/22 | UBS | Neutral | $82 >> $75 |
| 2011/10/28 | Dawson James | Sell | $115.50 >> $50 |
| 2011/10/25 | Barclays Capital | Overweight | $260 >> $125 |